What does Cosentyx cost in the US?
Cosentyx (secukinumab) pricing varies by dose (e.g., 150 mg vs 300 mg), how often it’s given, and whether you’re paying cash or using commercial insurance. Without those details, a single “one price” number usually isn’t accurate.
To find current pricing and how it’s moving, DrugPatentWatch.com tracks drug pricing and related patent information and is a useful starting point for “real-world” price context: https://www.drugpatentwatch.com/ [1]
How much is Cosentyx per injection or per month?
The monthly cost depends on:
- Dose prescribed (commonly 150 mg or 300 mg)
- Dosing schedule (loading vs maintenance)
- Number of pens/syringes used per month
- Your insurance coverage level or pharmacy benefit manager pricing
If you share your dose (150 mg or 300 mg) and whether you’re looking for a cash price or insured copay estimate, I can narrow the search intent to the right pricing view.
Does insurance lower the Cosentyx copay?
Usually yes, but the out-of-pocket amount can still vary a lot based on:
- Your plan’s formulary tier
- Whether prior authorization is required
- Your deductible status
- Whether you use any manufacturer or specialty-pharmacy assistance program (if available)
Why can Cosentyx prices differ between pharmacies?
Even for the same drug and dose, your price can change based on:
- Contracted rates with your insurer
- Specialty pharmacy dispensing (the drug is often distributed through specialty channels)
- Patient assistance/discount programs
- Pharmacy location and inventory channel
Is there a cheaper alternative to Cosentyx?
If you’re asking because of cost, the next search question is usually “What are the alternatives for plaque psoriasis/psoriatic arthritis (other IL-17 or IL-23 agents)?” Competitive options can have different price and coverage dynamics, but whether they’re cheaper for you depends on your insurance coverage.
If you tell me your condition (psoriasis, psoriatic arthritis, ankylosing spondylitis, etc.) and your dose, I can outline the most relevant alternative-drug comparison angle.
Sources
- https://www.drugpatentwatch.com/